News
Events
Overview
Rationale for Immunodrugs™
Strategy
Board & Management
Industry Collaborations
Letter of the CEO
History
Overview
Immunodrug™ Platform
Immunodrug™ Manufacturing
Scientific Collaborations
Scientific Publications
Pipeline
Clinical Trials
Disease Areas
Overview
Board & Management
Share Information
Bond Information
Analyst Coverage
Financial Calendar
Financial Reports
Corporate Governance
Stay Informed
Contact
Overview
Press Release Archive
Downloads
Picture Gallery
Contact
Company
History
Cytos
Press Releases
 
Cytos
Facts & Figures
 
Cytos Biotechnology AG
Wagistrasse 25
Postfach
8952 Schlieren
Switzerland
T +41 44 733 47 47
F +41 44 733 47 40
e-mail contact
Cytos Biotechnology GmbH was founded in February 1995 by Dr. Wolfgang A. Renner, the late Prof. Dr. James E. Bailey, and Prof. Dr. Hans M. Eppenberger as a spin-off company of the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. The company was transformed into a privately owned Swiss corporation in July 1998 (Aktiengesellschaft). In October 2002, Cytos Biotechnology completed its take-over of Asklia Holding AG. As a consequence, Cytos Biotechnology Ltd was publicly listed on the main board of the SIX Swiss Exchange on October 29, 2002 (SIX:CYTN).
image